Healio

Q&A: Albuterol-budesonide reduces severe exacerbation risks in mild asthma

Please provide your email address to receive an email when new articles are posted on . Patients with mild asthma are still at risk for severe exacerbations, which can impact their quality of life.
The American Journal of Managed Care

Combination of Albuterol/Budesonide a Game-Changer in Mild Asthma: Reynold Panettieri, Jr, MD

Mild asthma could be better treated with the recent approval of the combination of albuterol/budesonide. This is a real game changer. Why? The drug Airsupra, that is the combination of ...
Seeking Alpha

AIRSUPRA® (albuterol/budesonide) US prescribing information updated to reflect the statistically significant severe exacerbation risk reduction in patients with mild asthma ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AIRSUPRA’s US Prescribing Information now includes clinically meaningful evidence from the BATURA study in patients with mild asthma. 1 The BATURA Phase IIIb trial, ...
Monthly Prescribing Reference

As-Needed Albuterol/Budesonide Reduces Exacerbations in Patients With Mild Asthma

Severe exacerbation occurred in 5.1% of patients taking albuterol/budesonide compared with 9.1% of patients taking albuterol alone in the on-treatment efficacy population. Albuterol/budesonide ...
Healio

Albuterol-budesonide reduces asthma exacerbations regardless of history

Please provide your email address to receive an email when new articles are posted on . Patients had mild asthma and uncontrolled symptoms. Doses included an albuterol-budesonide combination or ...